Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03702205
Other study ID # ULS00005
Secondary ID
Status Recruiting
Phase Phase 2/Phase 3
First received
Last updated
Start date October 15, 2018
Est. completion date October 12, 2021

Study information

Verified date September 2020
Source Poznan University of Life Sciences
Contact Emilia E Zawieja, MSc
Phone +48 61 846 60 57
Email emilia.zawieja@up.poznan.pl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is aimed at assessing the influence of two betaine doses (2.5 g∙d-1 and 5 g∙d-1) supplemented for three weeks in a group of speed-strength trained athletes on anaerobic capacity in Wingate test, performance in CrossFit-like exercise test - Fight Gone Bad, alterations in body compositions and total body water.


Description:

The main aim of the project is the assessment of the effects of 3 weeks supplementation with two doses of betaine (2.5 g∙d-1 and 5 g∙d-1) on anaerobic capacity, CrossFit performance, body composition, and betaine metabolism in a group of male speed-strength trained athletes.

The study is designed as a double-blind, randomized, placebo-controlled crossover trial. 80 male participants will be divided randomly into two parallel groups: one receiving 2.5 g·d-1 betaine and the second receiving 5 g·d-1 betaine. In both experimental groups participants will receive both betaine supplement or placebo in a random order. The supplementation periods (betaine and placebo) will last for three weeks each and will be separated by a 3-week washout. The participants will attend four study meetings at the Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences, Poland. Food intake before and during the intervention will be assessed with the use of food diary and intakes of macro- and micronutrients will be calculated with the use of Dieta 5.0 software. On each visit Wingate ergocycling test will be performed, body composition will be measured and blood samples will be taken. The same day in the afternoon/evening hours the Fight Gone Bad (FGB) test will be performed. Body composition will be assessed based on air displacement plethysmography technology using the Bod Pod®. Moreover, total body water content will be analyzed by bioelectric impedance with the use of a BIA 101S analyzer. Anaerobic capacity will be assessed using the classical Wingate test on a cycloergometer. In order to assess CrossFit performance the FGB test will be performed. In blood samples the investigators plan to analyze concentrations of: lipoproteins and triglycerides (biochemical analyzer), betaine (LC-MS method), amino acid profile (LC-MS method), and testosterone (ELISA). MTHFR genotype will be analyzed with using a PCR-RFLP method. Data will be analyzed using the STATISTICA 12 software program.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date October 12, 2021
Est. primary completion date June 20, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- written informed consent from all participants before the study

- a current medical clearance to practice sports,

- training experience: at least 1 year (of CrossFit ttraining),

- minimum of 2 workout sessions (combat sport) a week,

Exclusion Criteria:

- current injury,

- any health-related contraindication,

- declared general feeling of being unwell,

- unwilling to follow the study protocol,

- serious disease or metabolic problems,

- intake of betaine, choline or creatine supplements 4 weeks before the beginning of the study.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Betaine supplementation
Group taking oral betaine supplementation
Placebo treatment
Group taking oral supplementation with placebo (starch) in a similar capsule form.

Locations

Country Name City State
Poland Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences Poznan

Sponsors (2)

Lead Sponsor Collaborator
Poznan University of Life Sciences National Science Centre, Poland

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in fat mass and fat free mass after betaine supplementation Fat mass (kg) and fat free mass (kg) analysis Baseline and after 3 weeks
Primary Changes in anaerobic capacity after betaine supplementation The Wingate cycling test (W) Baseline and after 3 weeks
Primary Changes in specific performance capacity after betaine supplementation The CrossFit-specific physical fitness test: Fight Gone Bad (reps.) Baseline and after 3 weeks
Secondary Changes in total body water after betaine supplementation Total body water content (%) Baseline and after 3 weeks
Secondary Changes in testosterone level (ng/L) after betaine supplementation Testosterone level (ng/L) Baseline and after 3 weeks
Secondary Changes in amino acid profile after betaine supplementation Amino acid profile (µmol/L) Baseline and after 3 weeks
Secondary Changes in blood betaine Blood betaine (µmol/L) Baseline and after 3 weeks
Secondary Changes in total, LDL and HDL cholesterol and triacylglycerol after betaine supplementation Total, LDL and HDL cholesterol (mg/dL) and triacylglycerol (mg/dL) Baseline and after 3 weeks
Secondary Difference in response to betaine supplementation depending on MTHFR (rs1801133) polymorphism MTHFR (rs1801133) polymorphism Baseline and after 3 weeks
See also
  Status Clinical Trial Phase
Completed NCT05597189 - Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain N/A
Recruiting NCT05444959 - The Impact of Exercise / Stress Stimuli on HMB Supplementation Efficacy Phase 2/Phase 3
Completed NCT03165357 - Sodium Bicarbonate Supplementation in Athletes Phase 3
Completed NCT03406065 - Sodium Bicarbonate Supplementation in Combat Sports Athletes Phase 2/Phase 3
Recruiting NCT04549610 - HMB and Exercise-induced Muscle Damage Phase 2/Phase 3
Completed NCT03822663 - The Influence of Caffeine Supplementation on Specific Performance and Training Activities Phase 3
Completed NCT06390670 - The Effect of Colostrum Bovinum Supplementation in Endurance Athletes Phase 2/Phase 3
Recruiting NCT05516212 - Caffeine Kinetics and CrossFit®-Specific Performance Phase 2/Phase 3
Completed NCT01235325 - The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients Phase 4
Completed NCT03028649 - The Effect of β-hydroxy-β-methylbutyrate Supplementation on Physical Capacity and Body Composition in Trained Athletes Phase 3
Completed NCT04427319 - The Efficacy β-Alanine Supplementation in Performance Outcomes of Road Professional Endurance Cyclists N/A
Completed NCT05750342 - Clinical Trial to Analyze the Efficacy of a Supplement Extracted From Persimmon on Overweight / Obesity. N/A
Active, not recruiting NCT03810404 - Acute Sodium Bicarbonate Supplementation in Athletes Phase 3
Completed NCT01275885 - Vitamin D Intervention in Infants - Pilot Phase 4
Completed NCT05525871 - Effects of Nitrates and Citrulline Malate on Performance in Professional Professional Soccer N/A
Recruiting NCT05878106 - Creatine Supplementation and Resistance Training in Patients With Breast Cancer N/A
Not yet recruiting NCT06327646 - Maternal Adherence to MMS in Nepal N/A